Atom Investors LP Mirum Pharmaceuticals, Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.57 - $34.85 $3,818 - $5,645	-162 Reduced 1.05%	15,268 $522,000
Q1 2024 May 15, 2024	BUY	$24.92 - $30.02 $124,026 - $149,409	4,977 Added 47.61%	15,430 $387,000
Q4 2023 Feb 14, 2024	SELL	$27.14 - $34.93 $72,979 - $93,926	-2,689 Reduced 20.46%	10,453 $308,000
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $111,278 - $148,416	4,518 Added 52.39%	13,142 $415,000
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $202,750 - $259,496	8,624 New	8,624 $223,000

194

54.1M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.79B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.